Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Plos One|June 24, 2016
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic CancerAwalpreet S Chadha, Heath D Skinner, Jillian R Gunther, et al.
Annals of Surgery|November 29, 2012
Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective studyJosé G Guillem, Jeannine A Ruby, Tobias Leibold, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trialsDario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute|July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, C David Fuller, Shalini Moningi, et al.
Cancer Research Communications|August 5, 2024
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology TrialsEsther J Beck, Alexander D Sherry, Marcus A Florez, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or MortalityJason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Advances in Radiation Oncology|April 29, 2021
Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic CancerShalini Moningi, Joseph Abi Jaoude, Ramez Kouzy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic CancerCharles X Wang, Dalia Elganainy, Mohamed M Zaid, et al.
Clinical and Translational Radiation Oncology|January 31, 2022
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experienceAlexander F Bagley, Ethan B Ludmir, Anirban Maitra, et al.
Practical Radiation Oncology|July 30, 2022
Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert PanelJohn Park, Bhanu Prasad Venkatesulu, Ksenija Kujundzic, et al.
Pageof 24